MPLN - MultiPlan Corporation
NYSE
->
Healthcare
->
Healthcare Plans
New York,
United States
Type: Equity
MPLN price evolution
MPLN
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $59.17 | $69.18 | $81.49 | |
| Short term investments | ||||
| Net receivables | $82.13 | $95.13 | $82.44 | $76.56 |
| Inventory | ||||
| Total current assets | $211.53 | $192.26 | $189.51 | $193.59 |
| Long term investments | ||||
| Property, plant & equipment | $306.44 | $304.13 | $296.34 | $287.11 |
| Goodwill & intangible assets | $5217.52 | $5857.19 | $6462.21 | |
| Total noncurrent assets | $5550.02 | $6177.19 | $6771.09 | |
| Total investments | ||||
| Total assets | $5319.2 | $5742.28 | $6366.69 | $6964.69 |
| Current liabilities | ||||
| Accounts payable | $22.55 | $22.29 | $18.04 | $19.59 |
| Deferred revenue | ||||
| Short long term debt | $18.07 | $17.97 | $18.04 | |
| Total current liabilities | $201.5 | $180.84 | $194.11 | $166.74 |
| Long term debt | $4510.24 | $4525.42 | $4527.2 | $4549.86 |
| Total noncurrent liabilities | $4958.08 | $5002.2 | $5088.82 | |
| Total debt | $4543.49 | $4545.17 | $4567.9 | |
| Total liabilities | $5111.64 | $5138.91 | $5196.31 | $5255.56 |
| Shareholders' equity | ||||
| Retained earnings | -$2007.17 | -$1615.72 | -$1039 | -$499.31 |
| Other shareholder equity | -$12.46 | -$1.12 | -$3.24 | -$11.78 |
| Total shareholder equity | $603.36 | $1170.38 | $1709.12 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $81.49 | $340.56 | $188.38 | $126.75 |
| Short term investments | ||||
| Net receivables | $76.56 | $78.91 | $99.91 | $63.2 |
| Inventory | ||||
| Total current assets | $193.59 | $446.74 | $319.26 | $208.85 |
| Long term investments | ||||
| Property, plant & equipment | $287.11 | $257.07 | $243.34 | $218.97 |
| Goodwill & intangible assets | $6462.21 | $6645.4 | $7648.11 | $7841.52 |
| Total noncurrent assets | $6771.09 | $6924.37 | $7901.15 | $8074.72 |
| Total investments | ||||
| Total assets | $6964.69 | $7371.1 | $8220.41 | $8283.58 |
| Current liabilities | ||||
| Accounts payable | $19.59 | $13.29 | $13.01 | $15.26 |
| Deferred revenue | ||||
| Short long term debt | $18.04 | $19.61 | $20.13 | $6.44 |
| Total current liabilities | $166.74 | $175.84 | $141.91 | $112.5 |
| Long term debt | $4549.86 | $4741.86 | $4905.87 | $4605.99 |
| Total noncurrent liabilities | $5088.82 | $5404.72 | $5733.83 | $5613.22 |
| Total debt | $4567.9 | $4782.36 | $4926 | $4612.43 |
| Total liabilities | $5255.56 | $5580.56 | $5875.74 | $5725.71 |
| Shareholders' equity | ||||
| Retained earnings | -$499.31 | -$347.8 | $225.11 | $117 |
| Other shareholder equity | -$11.78 | $0.39 | ||
| Total shareholder equity | $1709.12 | $1790.54 | $2344.67 | $2557.86 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $230.5 | $233.48 | $234.51 | $244.13 |
| Cost of revenue | $61.37 | $60.08 | $60.66 | |
| Gross Profit | $169.67 | $172.11 | $174.43 | $183.47 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $34.55 | $34.86 | $36.06 | |
| Total operating expenses | $146.27 | $696.03 | $660.87 | $142.66 |
| Operating income | -$523.93 | -$486.44 | $40.81 | |
| Income from continuing operations | ||||
| EBIT | -$523.12 | -$479.47 | $51.23 | |
| Income tax expense | -$27.22 | -$27.52 | -$21.98 | -$0.39 |
| Interest expense | -$80.46 | $81.13 | $82.2 | $83 |
| Net income | ||||
| Net income | -$391.45 | -$576.73 | -$539.69 | -$31.39 |
| Income (for common shares) | -$576.73 | -$539.69 | -$31.39 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $961.52 | $1079.72 | $1117.6 | $937.76 |
| Cost of revenue | $235.47 | $204.1 | $175.29 | $318.68 |
| Gross Profit | $726.06 | $875.62 | $942.31 | $619.09 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $144.06 | $166.84 | $151.09 | $355.63 |
| Total operating expenses | $564.07 | $1238.35 | $556.19 | $750.91 |
| Operating income | $161.98 | -$362.73 | $386.12 | -$131.82 |
| Income from continuing operations | ||||
| EBIT | $226.15 | -$257.34 | $402.93 | -$211.27 |
| Income tax expense | -$15.36 | $12.17 | $33.37 | -$26.34 |
| Interest expense | $333.21 | $303.4 | $267.48 | $335.64 |
| Net income | ||||
| Net income | -$91.7 | -$572.91 | $102.08 | -$520.56 |
| Income (for common shares) | -$91.7 | -$572.91 | $102.08 | -$520.56 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$576.73 | -$539.69 | -$31.39 | |
| Operating activities | ||||
| Depreciation | $108.85 | $108.22 | $108.04 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.32 | $5.69 | $4.66 | |
| Total cash flows from operations | $18.47 | $49.72 | $27.7 | |
| Investing activities | ||||
| Capital expenditures | -$25.45 | -$30.54 | -$31.34 | |
| Investments | ||||
| Total cash flows from investing | -$87.69 | -$25.45 | -$30.54 | -$31.34 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.28 | -$9.94 | -$1.57 | |
| Net borrowings | -$3.31 | -$18.2 | -$20.91 | |
| Total cash flows from financing | -$37.67 | -$3.04 | -$31.49 | -$22.48 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $15.67 | -$10.01 | -$12.32 | -$26.12 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$91.7 | -$572.91 | $102.08 | -$520.56 |
| Operating activities | ||||
| Depreciation | $425.79 | $415.66 | $412.06 | $403.68 |
| Business acquisitions & disposals | -$140.94 | -$149.43 | -$140.03 | |
| Stock-based compensation | $18.02 | $16.74 | $18.01 | $406.05 |
| Total cash flows from operations | $171.72 | $372.36 | $404.69 | $377.37 |
| Investing activities | ||||
| Capital expenditures | -$108.85 | -$89.73 | -$84.59 | -$70.81 |
| Investments | -$14.71 | $5.64 | ||
| Total cash flows from investing | -$249.79 | -$104.45 | -$228.38 | -$210.84 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$14.71 | -$100 | -$101.12 | |
| Net borrowings | -$165.82 | -$113.28 | -$10.89 | -$642.88 |
| Total cash flows from financing | -$180.99 | -$115.74 | -$114.68 | -$61.6 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$259.06 | $152.18 | $61.62 | $104.93 |
News
Fundamentals
| Market cap | $473.49M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 16.17M |
| Revenue | $942.61M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$1.54B |
| Revenue Q/Q | -5.07% |
| Revenue Y/Y | -1.66% |
| P/E ratio | -0.31 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.50 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$95.19 |
|---|---|
| ROA | -25.24% |
| ROE | N/A |
| Debt/Equity | 3.08 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.05 |
| Quick ratio | N/A |